135 related articles for article (PubMed ID: 23759586)
1. Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression.
Murray MY; Rushworth SA; Zaitseva L; Bowles KM; Macewan DJ
Cell Cycle; 2013 Jul; 12(13):2144-53. PubMed ID: 23759586
[TBL] [Abstract][Full Text] [Related]
2. Effect of miR-34a on the expression of clock and clock-controlled genes in DLD1 and Lovo human cancer cells with different backgrounds with respect to p53 functionality and 17β-estradiol-mediated regulation.
Moravčík R; Olejárová S; Zlacká J; Herichová I
PLoS One; 2023; 18(10):e0292880. PubMed ID: 37831728
[TBL] [Abstract][Full Text] [Related]
3. Myc overexpression brings out unexpected antiapoptotic effects of miR-34a.
Sotillo E; Laver T; Mellert H; Schelter JM; Cleary MA; McMahon S; Thomas-Tikhonenko A
Oncogene; 2011 Jun; 30(22):2587-94. PubMed ID: 21297663
[TBL] [Abstract][Full Text] [Related]
4. Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment.
Zarone MR; Misso G; Grimaldi A; Zappavigna S; Russo M; Amler E; Di Martino MT; Amodio N; Tagliaferri P; Tassone P; Caraglia M
Sci Rep; 2017 Dec; 7(1):17949. PubMed ID: 29263373
[TBL] [Abstract][Full Text] [Related]
5. Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis.
Abdi J; Rastgoo N; Li L; Chen W; Chang H
J Hematol Oncol; 2017 Oct; 10(1):169. PubMed ID: 29073933
[TBL] [Abstract][Full Text] [Related]
6. Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells.
Zhao Y; Bhattacharjee S; Jones BM; Hill J; Dua P; Lukiw WJ
Mol Neurobiol; 2014 Aug; 50(1):97-106. PubMed ID: 24293102
[TBL] [Abstract][Full Text] [Related]
7. MYC Causes Multiple Myeloma Progression via Attenuating TP53-Induced MicroRNA-34 Expression.
Murakami Y; Kimura-Masuda K; Oda T; Matsumura I; Masuda Y; Ishihara R; Watanabe S; Kuroda Y; Kasamatsu T; Gotoh N; Takei H; Kobayashi N; Saitoh T; Murakami H; Handa H
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672841
[TBL] [Abstract][Full Text] [Related]
8. SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma.
Du L; Liu W; Aldana-Masangkay G; Pozhitkov A; Pichiorri F; Chen Y; Rosen ST
J Exp Clin Cancer Res; 2022 Jan; 41(1):8. PubMed ID: 34983615
[TBL] [Abstract][Full Text] [Related]
9. The impact of oleuropein on miRNAs regulating cell death signaling pathway in human cervical cancer cells.
Amini-Farsani Z; Hashemi Sheikhshabani S; Shaygan N; Asgharzade S
Biotechnol Appl Biochem; 2024 Feb; 71(1):61-71. PubMed ID: 37849224
[TBL] [Abstract][Full Text] [Related]
10. Modification of tumor cell exosome content by transfection with wt-p53 and microRNA-125b expressing plasmid DNA and its effect on macrophage polarization.
Trivedi M; Talekar M; Shah P; Ouyang Q; Amiji M
Oncogenesis; 2016 Aug; 5(8):e250. PubMed ID: 27500388
[TBL] [Abstract][Full Text] [Related]
11.
Nelson HM; Qu S; Huang L; Shameer M; Corn KC; Chapman SN; Luthcke NL; Schuster SA; Turnbull LA; Guy LL; Liu X; Vickers KC; Liu Q; Franklin JL; Weaver AM; Rafat M; Coffey RJ; Patton JG
bioRxiv; 2024 May; ():. PubMed ID: 38826470
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of Non-Coding RNAs: Roles of miRNAs and lncRNAs in the Pathogenesis of Multiple Myeloma.
Ismail NH; Mussa A; Al-Khreisat MJ; Mohamed Yusoff S; Husin A; Al-Jamal HAN; Johan MF; Islam MA
Noncoding RNA; 2023 Nov; 9(6):. PubMed ID: 37987364
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-125b as a valuable predictive marker for outcome after autologous hematopoietic stem cell transplantation.
Rafiee M; Amiri F; Mohammadi MH; Hajifathali A
BMC Cancer; 2023 Mar; 23(1):202. PubMed ID: 36869286
[TBL] [Abstract][Full Text] [Related]
14. Ebastine exerts antitumor activity and induces autophagy by activating AMPK/ULK1 signaling in an IPMK-dependent manner in osteosarcoma.
Pan Z; Li SJ; Guo H; Li ZH; Fei X; Chang SM; Yang QC; Cheng DD
Int J Biol Sci; 2023; 19(2):537-551. PubMed ID: 36632464
[TBL] [Abstract][Full Text] [Related]
15. A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma.
Metselaar J; Lammers T; Boquoi A; Fenk R; Testaquadra F; Schemionek M; Kiessling F; Isfort S; Wilop S; Crysandt M
Drug Deliv Transl Res; 2023 Apr; 13(4):915-923. PubMed ID: 36592287
[TBL] [Abstract][Full Text] [Related]
16. Role of microRNAs and long non‑coding RNAs in glucocorticoid signaling (Review).
Pierouli K; Papageorgiou L; Mitsis T; Papakonstantinou E; Diakou I; Leptidis S; Sigala M; Dragoumani K; Spandidos DA; Bacopoulou F; Chrousos GP; Goulielmos GΝ; Eliopoulos E; Vlachakis D
Int J Mol Med; 2022 Dec; 50(6):. PubMed ID: 36367164
[TBL] [Abstract][Full Text] [Related]
17. Managing Cancer Drug Resistance from the Perspective of Inflammation.
Lu S; Li Y; Zhu C; Wang W; Zhou Y
J Oncol; 2022; 2022():3426407. PubMed ID: 36245983
[TBL] [Abstract][Full Text] [Related]
18. The role and significance of magnetic resonance imaging and miRNA-125b expression level in diagnosis of head and neck squamous cell carcinoma.
Huang Q; Zhang X; Gong B; Ge D
Postepy Dermatol Alergol; 2022 Feb; 39(1):110-115. PubMed ID: 35369634
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of exosomal miR-155 derived from bone marrow mesenchymal stem cells on stemness maintenance and drug resistance in myeloma cells.
Gao X; Zhou J; Wang J; Dong X; Chang Y; Jin Y
J Orthop Surg Res; 2021 Oct; 16(1):637. PubMed ID: 34689803
[TBL] [Abstract][Full Text] [Related]
20. miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma.
Caracciolo D; Riillo C; Juli G; Scionti F; Todoerti K; Polerà N; Grillone K; Fiorillo L; Arbitrio M; Di Martino MT; Neri A; Tagliaferri P; Tassone P
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503175
[No Abstract] [Full Text] [Related]
[Next] [New Search]
